Member Directory
Aptamer Group develops custom affinity binders for use across the life sciences, using its proprietary Optimer® platform.
Optimer binders can be used as antibody alternatives to offer novel or improved solutions for therapeutics, diagnostics, bioprocessing and analytical applications. Offering full platform compatibility, tuneable binding kinetics and high stability, Optimer binders are removing the barriers to innovation in the life sciences.
Aqdot is a specialist chemical company with a focus and expertise in intelligent encapsulation technology. . . Aqdot’s proprietary technology and know-how enables valuable active products to be protected, delivered and programmed to release where and when required. This unique and disruptive platform technology has the potential to be game-changing in a wide range of industries, including household products, fragrances, personal care, agrochemicals, composites / resin curing and pharmaceuticals. . . Identifying unmet needs in these sectors, we develop products that enable our customers to introduce novel and differentiated products, reduce manufacturing costs, and make a truly positive impact on the environment.
Arecor is the world leader at improving the durability of biologic medicines. Using a rational approach to formulation design, Arecor has generated proprietary technology for stabilising therapeutic proteins, antibodies and vaccines. Arecor has partnered with the world’s largest pharmaceutical companies to enable previously impossible delivery and use options for biologics. As an example of how effective these technologies are – in over 90 per cent of the cases – Arecor’s technology can enable: solid-to-liquid re-formulations; removal of cold-chain; high-concentration delivery, e.g. 200+ mg/ml; and co-formulation of incompatible components.
Aridom Sanex is dedicated to providing cutting-edge solutions for research laboratories and pharmaceutical companies. Our expertise lies in the application of dry fogging technology, hypochlorous acid, and water purification systems to ensure a safe and efficient working environment.
Our dry fogging technology is an innovative disinfection method that produces micro-droplets of a non-toxic solution, which effectively penetrates every room corner, leaving no surface untouched. A thorough and reliable disinfection eliminates harmful microorganisms, such as bacteria and viruses, without leaving any residue or harmful chemicals.
Hypochlorous acid is a powerful disinfectant produced naturally by the human body's immune system. Our company harnesses the power of hypochlorous acid to produce a safe and effective disinfectant solution suitable for use in research laboratories and pharmaceutical companies. It is a non-toxic, environmentally friendly, highly effective solution against a wide range of microorganisms.
We also offer a sustainable water purification system specifically designed for use in research laboratories and pharmaceutical companies. Our systems use advanced filtration and purification technologies to remove impurities and contaminants from water, ensuring that it is safe and suitable for research and manufacturing.
Our company is committed to providing our clients with the highest quality solutions that are both effective and safe. Our team of experts is dedicated to working with our clients to understand their specific needs and develop tailored solutions that meet their requirements.
Contact us today to learn more about how our dry fogging technology, hypochlorous acid, and water purification systems can help improve the safety and efficiency of your research laboratory or pharmaceutical company.
Where budding businesses, students and academics work side-by-side. Arise Innovation Hubs support health, performance and wellbeing companies looking for something more - a cultivating and innovative community with access to university facilities. Arise is a space for you to belong, with the support you need to succeed.
Offering a range of membership packages to suit all business needs whether that's dedicated office space in one of our hubs on our Chelmsford campus location or on the Harlow Science Park, the occasional use of a meeting room away from home, or a virtual address, Arise can help a businesses like yours grow.
Artios - Experts in DDR. We are developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to selectively kill cancer cells
Please watch our video about our open innovation program here https://www.youtube.com/watch?v=rWPkQAae-Cc
Astex is dedicated to the discovery and development of novel small molecule therapeutics with a primary focus on oncology. The Company, which is a recognised leader in the field of Fragment Based Drug Discovery, is developing a proprietary pipeline of novel therapies and has a number of other programmes partnered with major pharmaceutical companies with products in clinical development. . . In October 2013, Astex was acquired by Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan. . . For more information about Astex please visit http://www.astx.com
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.. . We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.. . We employ over 61,000 people (46% in Europe, 24% in the North America, 7% in Latin America and 24% in Asia, Africa and Australasia)